Related Experiment Video
Updated: Feb 6, 2026

Live Imaging of Chemokine Receptors in Zebrafish Neutrophils During Wound Responses
Published on: December 4, 2020
The Atypical Chemokine Receptor Ackr2 Constrains NK Cell Migratory Activity and Promotes Metastasis
Christopher A H Hansell1, Alasdair R Fraser1, Alan J Hayes1
1Chemokine Research Group, Institute of Infection, Immunity, and Inflammation, University of Glasgow, Glasgow G12 8TA, United Kingdom.
Abstract:
Chemokines have been shown to be essential players in a range of cancer contexts. In this study, we demonstrate that mice deficient in the atypical chemokine receptor Ackr2 display impaired development of metastasis in vivo in both cell line and spontaneous models. Further analysis reveals that this relates to increased expression of the chemokine receptor CCR2, specifically by KLRG1+ NK cells from the Ackr2-/- mice. This leads to increased recruitment of KLRG1+ NK cells to CCL2-expressing tumors and enhanced tumor killing. Together, these data indicate that Ackr2 limits the expression of CCR2 on NK cells and restricts their tumoricidal activity. Our data have important implications for our understanding of the roles for chemokines in the metastatic process and highlight Ackr2 and CCR2 as potentially manipulable therapeutic targets in metastasis.
Insights
Mice lacking atypical chemokine receptor Ackr2 showed reduced metastasis. This was due to enhanced natural killer (NK) cell activity against tumors, mediated by increased chemokine receptor CCR2 expression on NK cells.
Area of Science:
- Immunology
- Cancer Biology
- Molecular Biology
Background:
- Chemokines play crucial roles in cancer progression and metastasis.
- Atypical chemokine receptors (ACKRs) modulate chemokine signals, influencing immune responses.
- The specific role of ACKR2 in cancer metastasis is not fully understood.
Purpose of the Study:
- To investigate the role of atypical chemokine receptor Ackr2 in cancer metastasis.
- To elucidate the mechanisms by which Ackr2 influences anti-tumor immunity.
Main Methods:
- Utilized knockout mouse models deficient in Ackr2 (Ackr2-/-).
- Assessed metastasis development in cell line and spontaneous cancer models.
- Analyzed chemokine receptor expression (CCR2) on natural killer (NK) cells.
- Quantified NK cell recruitment to tumors and evaluated tumoricidal activity.
Main Results:
- Ackr2 deficiency led to impaired metastasis in vivo.
- Ackr2-/- mice exhibited increased expression of chemokine receptor CCR2 on KLRG1+ NK cells.
- Enhanced recruitment of KLRG1+ NK cells to CCL2-expressing tumors was observed.
- Increased NK cell activity resulted in enhanced tumor killing.
Conclusions:
- Ackr2 negatively regulates CCR2 expression on NK cells, thereby limiting their anti-tumor activity.
- Targeting Ackr2 and CCR2 may represent a novel therapeutic strategy for combating cancer metastasis.
More Related Videos
Related Concept Videos
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Internal Receptors
The Eukaryotic Promoter Region
Antipsychotic Drugs: Typical and Atypical Agents
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Types of Receptors: Cell Surface Receptors

